ApiFix Ltd.
Minimally invasive fusionless technique for adolescent scoliosis
This article was originally published in Start Up
Executive Summary
ApiFix Ltd. says its minimally invasive, fusionless technique for treating adolescent idiopathic scoliosis effectively remedies three hotly contested areas in spine: motion preservation, minimally invasive techniques and deformity correction. The device consists of an implantable ratcheting rod that only increases in length over a short segment of the spine, at the apex of the scoliotic curve, compared to a long segment) required for fusion surgery, and it requires only two pedicle screws to anchor the rod.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.